0.8657
-0.01 (-0.88%)
0.88
+0.01 (+1.65%)
ChartMill assigns a Buy % Consensus number of 75% to ZIOP. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 4. This target is 361.48% above the current price.
ZIOP was analyzed by 13 analysts. The buy percentage consensus is at 75. So analysts seem to be have mildly positive about ZIOP.
In the previous month the buy percentage consensus was at a similar level.
ZIOP was analyzed by 13 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2021-11-09 | Raymond James | Maintains | Market Perform |
| 2021-08-10 | Raymond James | Downgrade | Outperform -> Market Perform |
| 2021-05-07 | Raymond James | Maintains | Outperform |
| 2021-03-12 | Jefferies | Downgrade | Buy -> Hold |
| 2021-03-01 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
ZIOPHARM ONCOLOGY INC / ZIOP FAQ
Can you provide the average price target for ZIOPHARM ONCOLOGY INC stock?
13 analysts have analysed ZIOP and the average price target is 4 null. This implies a price increase of 361.48% is expected in the next year compared to the current price of 0.8657.
Can you provide the consensus rating for ZIOPHARM ONCOLOGY INC stock?
The consensus rating for ZIOPHARM ONCOLOGY INC (ZIOP) is 75.3846 / 100 . This indicates that analysts generally have a positive outlook on the stock.